期刊文献+

PI3K/Akt信号通路在肿瘤研究中的进展 被引量:31

下载PDF
导出
摘要 磷酯酰肌醇-3激酶/蛋白激酶B(PI3K/Akt)信号通路是肿瘤、炎症等发生发展过程中一条重要的信号通路。研究发现,在许多肿瘤组织中,PI3K/Akt信号通路过度表达和活化与肿瘤的进展密切相关。上游分子通过与PI3K结合,使其构象发生改变,从而磷酸化激活Akt,Akt的活化能调控其下游分子,参与肿瘤调控通路。近年来,PI3K/Akt信号通路在肿瘤中的重要作用受到众多学者的关注,多种肿瘤组织中检测到PI3K/Akt信号通路的过度活化,因此靶向该信号通路的研究成为研究热点。目前关于靶向PI3K/Akt信号通路的抗肿瘤药物在肿瘤治疗方面的临床试验已经展开,Wortmannin、LY294002等PI3K/Akt信号通路抑制剂有着广阔的临床应用前景。
作者 李建 周怀君
出处 《东南大学学报(医学版)》 CAS 2014年第3期392-395,共4页 Journal of Southeast University(Medical Science Edition)
  • 相关文献

参考文献32

  • 1ENGELMAN J A, LUO J, CANTLEY L C, et al. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism[ J]. Nat Rev Genet,2006,7:606-619.
  • 2ODA K, STOKOE D, TAKETANI Y, et al. High frequency of coexistent mutations of PIK3CA and PTEN genes inendometri- al carcinoma[ J ]. Cancer Res ,2005,65 ( 23 ) : 10669-10673.
  • 3SHAW R J,CANTLEY L C. Ras,PI(3)K and mTOR signaling controls tumour cell growth [ J ]. Nature, 2006,441 ( 7092 ) : 424-430.
  • 4KATSO R, OKKENHAUG K, AHMADI K, et al. Cellular func- tion of phosphoinositide 3-kinases: implications for develop- ment,homeostasis,and cancer [ J ]. Annu Rev Cell Dev Biol, 2001,17:615-675.
  • 5ZHAO L, VOGT P K. Class I PI3K in oncogenic cellular trans- formation[ J ]. Oncogene ,2008,27 ( 41 ) :5486-5496.
  • 6LEE H T, KAY E P. Regulatory role of cAMP on expression of Cdk4 and p27 ( Kipl ) by inhibiting phosphatidylionositol 3- ki- nase in corneal endothelial cells [ J ]. Invest Ophthalmol Vis Sci,2003,44(9) :3816-3825.
  • 7MAIRA S M,FINAN P,GARCIA-ECHEVERRIA C. From the bench to the bed side:PI3K pathway inhibitors in clinical de- velopment [ J ]. Curr Top Microbiol Immunol, 2010, 347: 209- 239.
  • 8WARD S G,FINAN P. Isoform-specific phosphoinesitide 3-ki-nase inhibitors as therapeutic agents [ J ]. Current Opinion In Phammaology, 2003,3 ( 4 ) : 426 - 434.
  • 9ENGELMAN J A, LUO J, CANTLEY L C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and me- tabolism [ J ]. Nat Rev Genet ,2006,7:606-619.
  • 10SHI F, WANG Y C, ZHAO T Z, et al. Effects of simulated mi- crogravity on human umbilical vein endothelial cell angiogen- esis and role of the PI3K-Akt-eNOS signal Pathway[J]. PLoS ONE, 2012,7 (7) : e40365.

二级参考文献44

  • 1石松长,黄昌明.PI_3K[MS1]/Akt信号通路与消化道肿瘤的研究进展[J].医学综述,2007,13(14):1070-1072. 被引量:5
  • 2MARCHETFI S, MAZZANTI R, BEUNEN J H, et al. Concise review : clinical relevance of drug- drug and herb- drug inter- actions mediated by the ABC transporter ABCB1 ( MDR1, P- glycoprotein ) [ J ]. Oncologist, 2007,12 ( 8 ) : 927- 941.
  • 3FUJITA T, WASHIO K, TAKABATAKE D, et al. Proteasome inhibitors canalter the signaling pathways and attenuate the P- glycoprotein- mediated multidrug resistance [ J ]. Int J Cancer, 2005,117 (4) : 670- 682.
  • 4SHINODA C, MARUYAMA M, FUJISHITA T,et al. Doxorubi- cininduces expression of muhidrug resistance-associated pro- tein 1 inhuman small cell lung cancer cell lines by the c-jun N- terminal kinase pathway J ]. Int J Cancer, 2005,117 ( 1 ) : 21-31.
  • 5CHOI B H,KIM C G, LIM Y,et al. Curcumin down-regulates the multidrug-resistance mdrlb gene by inhibiting the PI3K/ Akt/NF kappa B pathway [ J 1. Cancer Lett, 2008,259 ( 1) : 111-118.
  • 6LI H,YU J P, CAO J, et al. Effect of PI3K/Akt inhibitor on the expression of caspase-9 in human gastric cancer cells [ J ] Med J Wuhan Univ,2008,29( 1 ) :38-40.
  • 7LEE J T, STEELMAN L S, MCCUBREY J A. Phosphatidyli- nositol 3'-kinase activation leads to multidrug resistance pro- tein- 1 expression and subsequent chemo-resistance in ad- vanced prostate cancer cells[ J ]. Cancer Res ,2004,64 (22) : 8397- 8404.
  • 8ABDUL-GHANI R, SERRA V, GYORFFY B, et al. The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1 [ J ]. Oncogene ,2006,25 (12) :1743-1752.
  • 9PAGE C, LIN H J, JIN Y, et al. Overexpression of Akt/Akt can modulate chemotherapy- induced apoptosis [ J ]. Antican- cer Res,2000,20(1A) :407-416.
  • 10ZHANG H Y,ZHANG P N, SUN H. Aberration of the PI3K/ AKT/mTOR signaling in epithelial ovarian cancer and its im- plication in cisplatin- based chemotherapy [ J ]. Eur J Obstet Gynecol Reprod Bio1,2009,146( 1 ) :81-86.

共引文献13

同被引文献438

引证文献31

二级引证文献210

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部